Targeting in Cancer Therapies
Acknowledgments
Conflicts of Interest
References
- Sanchez-Garcia, L.; Martín, L.; Mangues, R.; Ferrer-Miralles, N.; Vázquez, E.; Villaverde, A. Recombinant pharmaceuticals from microbial cells: A 2015 update. Microb. Cell Fact. 2016, 15, 33. [Google Scholar]
- Torchilin, V.P. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 2014, 13, 813–827. [Google Scholar] [CrossRef] [PubMed]
- Bertrand, N.; Leroux, J.C. The journey of a drug-carrier in the body: An anatomo-physiological perspective. J. Control. Release 2012, 161, 152–163. [Google Scholar] [CrossRef] [PubMed]
- Duncan, R.; Gaspar, R. Nanomedicine(s) under the microscope. Mol. Pharm. 2011, 8, 2101–2141. [Google Scholar] [CrossRef] [PubMed]
- Undevia, S.D.; Gomez-Abuin, G.; Ratain, M.J. Pharmacokinetic variability of anticancer agents. Nat. Rev. Cancer 2005, 5, 447–458. [Google Scholar] [CrossRef] [PubMed]
- Petros, R.A.; DeSimone, J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9, 615–627. [Google Scholar] [CrossRef] [PubMed]
- Lytton-Jean, A.K.; Kauffman, K.J.; Kaczmarek, J.C.; Langer, R. Cancer nanotherapeutics in clinical trials. Cancer Treat. Res. 2015, 166, 293–322. [Google Scholar] [PubMed]
- Sievers, E.L.; Senter, P.D. Antibody-drug conjugates in cancer therapy. Annu. Rev. Med. 2013, 64, 15–29. [Google Scholar] [CrossRef] [PubMed]
- Senter, P.D.; Sievers, E.L. The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Nat. Biotechnol. 2012, 30, 631–637. [Google Scholar] [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mangues, R.; Vázquez, E.; Villaverde, A. Targeting in Cancer Therapies. Med. Sci. 2016, 4, 6. https://doi.org/10.3390/medsci4010006
Mangues R, Vázquez E, Villaverde A. Targeting in Cancer Therapies. Medical Sciences. 2016; 4(1):6. https://doi.org/10.3390/medsci4010006
Chicago/Turabian StyleMangues, Ramon, Esther Vázquez, and Antonio Villaverde. 2016. "Targeting in Cancer Therapies" Medical Sciences 4, no. 1: 6. https://doi.org/10.3390/medsci4010006
APA StyleMangues, R., Vázquez, E., & Villaverde, A. (2016). Targeting in Cancer Therapies. Medical Sciences, 4(1), 6. https://doi.org/10.3390/medsci4010006